Literature DB >> 17549277

Anaesthetic management of awake craniotomy for tumour resection.

Jee-Jian See1, Thomas W K Lew, Tong-Kiat Kwek, Ki-Jinn Chin, Mary F M Wong, Qui-Yin Liew, Siew-Hoon Lim, Hwee-Shih Ho, Yeow Chan, Genevieve P Y Loke, Vincent S T Yeo.   

Abstract

INTRODUCTION: Awake craniotomy allows accurate localisation of the eloquent brain, which is crucial during brain tumour resection in order to minimise risk of neurologic injury. The role of the anaesthesiologist is to provide adequate analgesia and sedation while maintaining ventilation and haemodynamic stability in an awake patient who needs to be cooperative during neurological testing. We reviewed the anaesthetic management of patients undergoing an awake craniotomy procedure.
MATERIALS AND METHODS: The records of all the patients who had an awake craniotomy at our institution from July 2004 till June 2006 were reviewed. The anaesthesia techniques and management were examined. The perioperative complications and the outcome of the patients were noted.
RESULTS: There were 17 procedures carried out during the study period. Local anaesthesia with moderate to deep sedation was the technique used in all the patients. Respiratory complications occurred in 24% of the patients. Hypertension was observed in 24% of the patients. All the complications were transient and easily treated. During cortical stimulation, motor function was assessed in 16 patients (94%). Three patients (16%) had lesions in the temporal-parietal region and speech was assessed intraoperatively. Postoperative motor weakness was seen in 1 patient despite uneventful intraoperative testing. No patient required intensive care unit stay. The median length of stay in the high dependency unit was 1 day and the median length of hospital stay was 9 days. There was no in-hospital mortality.
CONCLUSION: Awake craniotomy for brain tumour excision can be successfully performed under good anaesthetic conditions with careful titration of sedation. Our series showed it to be a well-tolerated procedure with a low rate of complications. The benefits of maximal tumour excision can be achieved, leading to potentially better patient outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17549277

Source DB:  PubMed          Journal:  Ann Acad Med Singap        ISSN: 0304-4602            Impact factor:   2.473


  7 in total

Review 1.  Clinical applications of neurolinguistics in neurosurgery.

Authors:  Peng Wang; Zehao Zhao; Linghao Bu; Nijiati Kudulaiti; Qiao Shan; Yuyao Zhou; N U Farrukh Hameed; Yangming Zhu; Lei Jin; Jie Zhang; Junfeng Lu; Jinsong Wu
Journal:  Front Med       Date:  2021-05-12       Impact factor: 4.592

2.  The effect of single low-dose dexamethasone on vomiting during awake craniotomy.

Authors:  Kotoe Kamata; Nobutada Morioka; Takashi Maruyama; Noriaki Komayama; Masayuki Nitta; Yoshihiro Muragaki; Takakazu Kawamata; Makoto Ozaki
Journal:  J Anesth       Date:  2016-08-29       Impact factor: 2.078

Review 3.  Anaesthetic interventions for prevention of awareness during surgery.

Authors:  Anthony G Messina; Michael Wang; Marshall J Ward; Chase C Wilker; Brett B Smith; Daniel P Vezina; Nathan Leon Pace
Journal:  Cochrane Database Syst Rev       Date:  2016-10-18

Review 4.  Awake craniotomy: A qualitative review and future challenges.

Authors:  Mahmood Ghazanwy; Rajkalyan Chakrabarti; Anurag Tewari; Ashish Sinha
Journal:  Saudi J Anaesth       Date:  2014-10

5.  Awake craniotomy for tumor resection.

Authors:  Mohammadali Attari; Sohrab Salimi
Journal:  Adv Biomed Res       Date:  2013-07-30

Review 6.  Anaesthesia Management for Awake Craniotomy: Systematic Review and Meta-Analysis.

Authors:  Ana Stevanovic; Rolf Rossaint; Michael Veldeman; Federico Bilotta; Mark Coburn
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

7.  Resting state functional connectivity magnetic resonance imaging integrated with intraoperative neuronavigation for functional mapping after aborted awake craniotomy.

Authors:  Prag Batra; S Kathleen Bandt; Eric C Leuthardt
Journal:  Surg Neurol Int       Date:  2016-02-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.